Mesa AZ 急性双表型白血病临床试验
3项针对 急性双表型白血病的研究正在 Mesa及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- Banner Children's at Desert, Mesa
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- Banner Children's at Desert, Mesa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Banner Children's at Desert, Mesa
其他城市的 急性双表型白血病试验
- Seattle, WA15 项研究
- Houston, TX11 项研究
- New York City, NY10 项研究
- Atlanta, GA9 项研究
- Durham, NC8 项研究
- Memphis, TN7 项研究
- Chicago, IL7 项研究
- Charlotte, NC6 项研究
- Aurora, CO6 项研究
- Baldwin Park, CA6 项研究
- Portland, OR6 项研究
- Los Angeles, CA6 项研究
Mesa的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。